Drug Combination Details
| General Information of the Combination (ID: C97676) | |||||
|---|---|---|---|---|---|
| Name | Yomogin + Tretinoin | + | 1,25-dihydroxyvitamin D3 | ||
| Click to Show/Hide the Each NP or Drug Information of This Combination | |||||
| Name | Yomogin NP Info | Drug Info | |||
| Structure |
|
|
|||
| Name | Tretinoin NP Info | ||||
| Structure |
|
|
|||
| Disease |
Acute lymphoblastic leukemia
[ICD-11: 2B33]
|
Investigative | [1] | ||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. Enhancing Drug Efficacy by This Combination | ||||||
| Achieving Therapeutic Synergy | Click to Show/Hide | |||||
| Experiment 1 Reporting the Effect of This Combination | [1] | |||||
| In-vitro Model | HL-60 | CVCL_0002 | Adult acute myeloid leukemia | Homo sapiens | ||
| Experimental
Result(s) |
Yomogin may be useful in combination with 1,25-(OH)(2) D(3) or all- trans-RA in the differentiation therapy for myeloid leukemias. | |||||